[Flupenthixol versus haloperidol in acute psychotic episodes]. 1982

M Parent, and C Toussaint

The aim of this study is to evaluate the activity of flupentixol oral high concentration and to define the profile of the drug according to the administered dose. The trial includes 40 acute patients (21 schizophrenics, 13 manic patients and 6 other psychotics). The study was open, but the patients were treated at random either by haloperidol or by flupentixol. Both substances showed a strong antipsychotic and antimanic effect. The differences according to the administered doses were: a quicker onset of action for flupentixol in schizophrenic patients; a more pronounced activity of flupentixol in the same patients, as far as anxiety, depressive tendencies and defect symptoms are concerned. Extrapyramidal side effects are the most common ones amongst the two drugs.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005475 Flupenthixol A thioxanthene neuroleptic that, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. (From Martindale, The Extra Pharmacopoeia, 30th ed, p595) Emergil,Fluanxol,Flupentixol,alpha-Flupenthixol,cis-Flupenthixol
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Parent, and C Toussaint
June 1969, Current therapeutic research, clinical and experimental,
M Parent, and C Toussaint
July 2000, Indian journal of psychiatry,
M Parent, and C Toussaint
March 1998, The Nursing clinics of North America,
M Parent, and C Toussaint
January 1980, International pharmacopsychiatry,
M Parent, and C Toussaint
January 2006, L'Encephale,
M Parent, and C Toussaint
February 2008, Progress in neuro-psychopharmacology & biological psychiatry,
M Parent, and C Toussaint
May 2022, Current opinion in psychiatry,
M Parent, and C Toussaint
November 1969, The British journal of psychiatry : the journal of mental science,
M Parent, and C Toussaint
March 1953, The Medical clinics of North America,
M Parent, and C Toussaint
October 1999, Psychiatry and clinical neurosciences,
Copied contents to your clipboard!